孟德尔随机化分析提示IL-1细胞因子家族蛋白中IL1RL1可能是创伤性脑损伤预后的因果贡献因素
该研究采用双样本孟德尔随机化分析,利用公开的全基因组关联研究汇总统计,评估循环IL-1家族蛋白水平对创伤性脑损伤结局的因果效应,以逆方差加权法为主要分析方法。结果显示,遗传预测的循环IL1RL1(可溶性ST2)水平较高与创伤性脑损伤不良结局风险增加相关(IVW β=0.22,标准误=0.084,P=0.010),但反向检验把握度不足。敏感性分析效应估计一致,未发现水平多效性证据。作者结论认为 Elevated circulating IL1RL1 levels are causally linked to worse TBI outcomes,提示IL-33/IL1RL1轴是机制相关且可能可修改的治疗靶点。
要点
- 遗传预测的循环IL1RL1(可溶性ST2)水平升高与创伤性脑损伤不良结局风险增加相关(IVW β=0.22,SE=0.084,P=0.010)。
- 敏感性分析显示效应估计一致,未发现水平多效性证据。
- 反向方向检验把握度不足,原文报告为underpowered。
- 作者认为IL-33/IL1RL1轴是机制相关且可能可修改的改善TBI恢复的治疗靶点。
适用人群与场景
- 创伤性脑损伤(TBI)患者,基于公开全基因组关联研究汇总统计的遗传预测人群。
研究设计与关键结果
- 研究类型:双样本孟德尔随机化分析,使用公开全基因组关联研究汇总统计,以逆方差加权(IVW)为主要分析方法。
- 主要结果:遗传预测的循环IL1RL1(可溶性ST2)水平较高与创伤性脑损伤不良结局风险增加相关(IVW β=0.22,标准误=0.084,P=0.010)。
- 敏感性分析:效应估计一致,未发现水平多效性证据。
- 反向方向:原文报告把握度不足(underpowered)以检验反向因果。
证据类型、等级与局限
- 证据类型:孟德尔随机化分析(双样本)。
- 局限:原文报告反向方向检验把握度不足(underpowered)。
对床旁实践的改变
- 作者认为IL-33/IL1RL1轴是机制相关且可能可修改的改善TBI恢复的治疗靶点。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Traumatic brain injury (TBI) is a leading preventable cause of death and disability worldwide. Inflammatory mechanisms contribute to secondary brain injury, and the interleukin-1 (IL-1) cytokine family has emerged as a potential contributor. However, whether circulating IL-1-family cytokines causally influence TBI outcomes remains unknown.
METHODS: We performed a two-sample Mendelian randomization (MR) analysis to evaluate the causal effects of circulating IL-1-family protein levels on TBI outcomes, using inverse-variance weighting (IVW) as the primary analytic method and publicly available genome-wide association study summary statistics.
RESULTS: Higher genetically predicted circulating IL1RL1 (soluble ST2) levels were associated with an increased risk of unfavorable TBI outcomes (IVW β = 0.22, standard error [SE] = 0.084, P = 0.010), although we were underpowered to test the reverse direction. Sensitivity analyses demonstrated consistent effect estimates with no evidence of horizontal pleiotropy.
CONCLUSIONS: These findings provide genetic evidence that elevated circulating IL1RL1 levels are causally linked to worse TBI outcomes. This suggests the IL-33/IL1RL1 axis as a mechanistically relevant, and potentially modifiable, therapeutic target for improving recovery after TBI.
参考来源
- Bhak Y, Helmy A, Needham EJ, et al. Mendelian Randomization Analysis of the IL-1 Cytokine Family Proteins Identifies IL1RL1 as a Potential Causal Contributor to Traumatic Brain Injury Prognosis. Neurocrit Care. 2026. PMID: 42521903. doi:10.1007/s12028-026-02575-3
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。